Respiratory Medicine
Volume 103, Issue 11 , Pages 1746-1754 , November 2009

Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats

  • Ka H. Chan

      Affiliations

    • Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • Siu P. Ho

      Affiliations

    • Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • Sze C. Yeung

      Affiliations

    • Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • Wallace H.L. So

      Affiliations

    • Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • C.H. Cho

      Affiliations

    • Department of Pharmacology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
  • ,
  • Marcel W.L. Koo

      Affiliations

    • Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • Wah K. Lam

      Affiliations

    • Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • Mary S.M. Ip

      Affiliations

    • Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • Ricky Y.K. Man

      Affiliations

    • Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • ,
  • Judith C.W. Mak

      Affiliations

    • Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
    • Department of Pharmacology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
    • Research Centre of Heart, Brain, Hormone and Healthy Aging, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
    • Corresponding Author InformationCorresponding author. Division of Respiratory and Critical Care Medicine, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Room 804, Administration Block, Pokfulam Road, Hong Kong SAR, China. Tel.: +852 28555886; fax: +852 28186474.

Received 13 December 2008 ,Accepted 28 April 2009.

References 

  1. American Lung Association, Epidemiology and Statistics Unit, Research and Program Services [Online]. Available from: http://www.lungusa.org/atf/cf/%7B7A8D42C2-FCCA-4604-8ADE-7F5D5E762256%7D/COPD1.PDF; 2005 May [cited 2008 Jun].
  2. Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Online]. Available from: http://www.goldcopd.com; 2008 Nov [cited 2008 Dec].
  3. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269–280
  4. Church T, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985;64:111–126
  5. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008;31:1334–1356
  6. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med. 2007;28:479–513
  7. Lagente V, Planquois JM, Leclerc O, Schmidlin F, Bertrand CP. Oxidative stress is an important component of airway inflammation in mice exposed to cigarette smoke or lipopolysaccharide. Clin Exp Pharmacol Physiol. 2008;35:601–605
  8. Rahman I. Antioxidant therapies in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1:15–29
  9. Kinnula VL, Ilumets H, Myllarniemi M, Sovijarvi A, Rytila P. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J. 2007;29:51–55
  10. Reiter RJ. Free radicals, melatonin, and cellular antioxidative defence mechanisms. Path Immun Neuroendocrin Comm Cir. 1994;35:135–160
  11. Churg A, Cosio M, Wright JL. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol. 2008;294:L612–L631
  12. Martin JG, Tamaoka M. Rat models of asthma and chronic obstructive lung disease. Pulm Pharmacol Ther. 2006;19:377–385
  13. Goven D, Boutten A, Lecon-Malas V, et al. Altered Nrf2/Keap1–Bach1 equilibrium in pulmonary emphysema. Thorax. 2008;63:916–924
  14. Morissette MC, Vachon-Beaudoin G, Parent J, Chakir J, Milot J. Increased p53 level, Bax/BCL-XL ratio, and TRAIL receptors expression in human emphysema. Am J Respir Crit Care Med. 2008;178:240–247
  15. Martorana PA, Beume R, Lucattelli M, Wollin L, Lungarella G. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. Am J Respir Crit Care Med. 2005;172:848–853
  16. Stevenson CS, Docx C, Webster R, et al. Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1183–L1193
  17. Thelle DS. Coffee, tea and coronary heart disease. Curr Opin Lipidol. 1995;6:25–27
  18. Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int J Oncol. 1996;8:221–238
  19. Kohlmeier L, Weterings KGC, Steck S, Kok FJ. Tea and cancer prevention: an evaluation of the epidemiologic literature. Nutr Cancer. 1997;27:1–13
  20. Rice-Evans C. Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Proc Soc Exp Biol Med. 1999;220:262–266
  21. Rice-Evans C. The screening of phenolics and flavonoids for antioxidant activity. In:  Packer L,  Hiramatsu M,  Yoshikawa T editor. Antioxidant food supplements and human health. San Diego: Academic Press; 1999;
  22. Chow JYC, Ma L, Cho CH. An experimental model for studying passive cigarette smoking effects on gastric ulceration. Life Sci. 1996;58:2415–2422
  23. Bramer SL, Kallungal BA. Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers. 2003;8:187–203
  24. D'hulst Al, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J. 2005;26:204–213
  25. Abbe MR. Automated assay of SOD in blood. Clin Chem. 1986;19:175–180
  26. Aebi H. Catalase in vitro. Meth Enzymol. 1984;105:121–126
  27. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801–809
  28. Dulloo AG, Duret C, Rohrer D, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999;70:1040–1045
  29. Kao YH, Hiipakka RA, Lio S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology. 2000;141:980–987
  30. Chantre P, Lairon D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine. 2002;9:3–8
  31. Chan CC, Koo MW, Ng EH, Tang OS, Yeung WS, Ho PC. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome – a randomized placebo-controlled trial. J Soc Gynecol Investig. 2006;13:63–68
  32. Lee JH, Lee DS, Kim EK, et al. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med. 2005;172:987–993
  33. Stocks J, Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology. 2003;8:266–285
  34. Gilliland FD, Berhane K, McConnell R, et al. Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax. 2000;55:271–276
  35. Rizzi M, Sergi M, Andreoli A, Pecis M, Bruschi C, Fanfulla F. Environmental tobacco smoke may induce early lung damage in healthy male adolescents. Chest. 2004;125:1387–93
  36. Lee SY, Kang EJ, Hur GY, et al. The inhibitory effects of rebamipide on cigarette smoke-induced airway mucin production. Respir Med. 2006;100:503–511
  37. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198–1203
  38. McCusker K, Hoidal J. Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smoke-exposed hamsters. Am Rev Respir Dis. 1990;141:678–682
  39. Gilks CB, Price K, Wright JL, Churg A. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathol. 1998;152:269–278
  40. Harju T, Kaarteenaho-Wiik R, Sirviö R, et al. Manganese superoxide dismutase is increased in the airways of smokers' lungs. Eur Respir J. 2004;24:765–771
  41. Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med. 2003;167:1600–1619
  42. Serafini M, Ghisellii A, Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr. 1996;50:28–32
  43. Klaunig JE, Xu Y, Han C, et al. The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med. 1999;220:249–254
  44. Bu-Abbas A, Clifford MN, Walker R, Ioannides C. Contribution of caffeine and flavanols in the induction of hepatic phase II activities by green tea. Food Chem Toxicol. 1998;36:617–621
  45. Levites Y, Weinreb O, Maor G, Youdim MBH, Mandel S. Green tea polyphenol (−)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem. 2001;78:1073–1082
  46. Nagaya N, Yamamoto H, Uematsu M, et al. Green tea reverses endothelial dysfunction in healthy smokers. Heart. 2004;90:1485–1486

PII: S0954-6111(09)00149-8

doi: 10.1016/j.rmed.2009.04.027

Respiratory Medicine
Volume 103, Issue 11 , Pages 1746-1754 , November 2009